2017-03-20,Palatin Technologies Receives Notice Of Allowance On Bremelanotide Methods Of Use Patent For Treatment Of Hypoactive Sexual Desire Disorder In Premenopausal Women
2017-03-09,Palatin Technologies To Present At The 29th Annual ROTH Conference
2017-02-03,Palatin Technologies Announces Closing Of License Agreement With AMAG Pharmaceuticals For North American Rights To Rekynda™
2017-01-10,Palatin Technologies To Hold Call Following Closing Of Licensing Agreement For North American Rights To Rekynda™
2016-12-07,Palatin Technologies Closes On $16.5 Million Financing
2016-12-01,Palatin Technologies Announces Pricing Of Public Offering Of Common Stock And Warrants
2016-11-30,Palatin Technologies Announces Proposed Public Offering Of Common Stock And Warrants
2016-11-02,How to Trade Today's Most Active Stocks -- Ford, Palatin, More
2016-11-02,Palatin Female Libido-Boosting Shot Fails Crucial Sex Frequency Test
2016-11-01,Bremelanotide Meets Co-Primary Endpoints In Palatin's Phase 3 Trials For Hypoactive Sexual Desire Disorder
2016-09-23,Palatin Technologies Receives Audit Opinion With Going Concern Explanation
2016-09-23,Palatin Technologies Presents Bremelanotide Neurobiology And Treatment Efficacy Review At World Meeting On Sexual Medicine
2016-08-08,Palatin Technologies To Present At The 36th Annual Canaccord Genuity Growth Conference
2016-08-04,Palatin Technologies Announces Closing Of $9.2 Million Financing
2016-08-04,Palatin Technologies Announces Completion Of All Patient Visits In Phase 3 Clinical Trials Of Bremelanotide For Hypoactive Sexual Desire Disorder
2016-08-01,Palatin Technologies Announces $9.25 Million Financing
2016-06-06,Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property
2016-05-26,Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property
2016-02-26,Palatin Technologies Presents Bremelanotide Alcohol Interaction Study At International Society For The Study Of Women's Sexual Health Annual Meeting
2016-02-08,Palatin Technologies Strengthens Intellectual Property Surrounding Use Of Bremelanotide For Female Sexual Dysfunction
2016-02-04,Palatin Technologies To Present At The BIO CEO & Investor Conference
2015-12-10,Palatin Technologies Achieves Target Patient Enrollment In Pivotal Phase 3 Studies For Bremelanotide For Female Sexual Dysfunction
2015-10-06,Insider Trading Alert - AEL, PTN And BSX Traded By Insiders
2015-09-28,Preclinical Data On PL-3994 For Heart Failure And Resistant Hypertension Presented At 2015 Heart Failure Society Of America Annual Meeting
2015-09-21,Palatin Technologies And Richter Terminate License Agreement For Bremelanotide For Female Sexual Dysfunction
2015-08-20,Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'
2015-08-19,Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'
2015-08-18,Palatin Technologies Supports FDA's Approval Of The First-Ever Treatment For Female Sexual Dysfunction
2015-07-06,Palatin Technologies Completes $30 Million Financing
2015-06-08,Palatin Technologies (PTN) Strong On High Relative Volume Today
2015-06-05,Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment
2015-06-04,Palatin Supports FDA Advisory Committee's Recommendation To Approve The First-Ever Treatment For Hypoactive Sexual Desire Disorder
2015-04-21,3 Stocks Under $10 to Trade for Breakouts
2015-03-06,Palatin Technologies To Present At The 27th Annual ROTH Conference
2015-02-20,Palatin Launches Reconnectstudy.com In Support Of Bremelanotide Phase 3 Program For Female Sexual Dysfunction
2015-02-06,Palatin Technologies To Present At The BIO CEO & Investor Conference
2014-12-29,Palatin Announces Start Of Bremelanotide Phase 3 Program For Female Sexual Dysfunction
2014-12-24,Palatin Completes $20 Million Equity And $10 Million Debt Financings
2014-10-08,Palatin Technologies To Present At The 13th Annual BIO Investor Forum
2014-09-03,Palatin Technologies Licenses Bremelanotide In Europe And Other Selected Countries To Richter
2014-08-27,3 Stocks Pushing The Drugs Industry Lower
2014-07-09,Palatin Technologies Announces Notification Of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
2014-06-27,Palatin Technologies To Join Russell Microcap Index
2014-06-10,Palatin Technologies Announces Notification Of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides
2014-05-06,Palatin Technologies Presents At The American Psychiatric Association (APA)
2014-05-01,Palatin Technologies Announces Option Exercise By Specialty Pharmaceutical Company To License Bremelanotide In Europe
2014-04-29,Palatin Technologies Presents At The Annual Clinical Meeting Of The American College Of Obstetricians And Gynecologists (ACOG)
2014-03-31,Palatin Technologies Announces Option Extension For License To Bremelanotide In Europe
2014-03-06,Palatin Technologies To Present At The 26Th Annual ROTH Conference
2014-02-24,Palatin Technologies Presents Positive New Data Analyses Demonstrating Efficacy Of Bremelanotide In Female Hypoactive Sexual Desire Disorder
2014-01-30,Palatin Technologies To Present At The 16th Congress Of The European Society For Sexual Medicine
2014-01-23,Palatin Technologies, Inc. Receives $1.85 Million From Sale Of New Jersey State Tax Credits
2014-01-16,Palatin Technologies To Present At "TEN", Noble Financial Capital Markets' Tenth Annual Equity Conference
2014-01-13,Palatin Technologies Responds To Unusual Market Activity
2013-12-02,Palatin Technologies To Participate In The 25th Annual Piper Jaffray Healthcare Conference
2013-11-25,Palatin Technologies, Inc. And PHT Corporation To Present On Best Practices In Female Sexual Dysfunction (FSD) Clinical Study Design At Managing ECOA Data Summit
2013-11-13,Palatin Technologies Announces Option For License To Bremelanotide In Europe
2013-11-12,Palatin Technologies Announces Issuance Of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
2013-10-28,Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
2013-10-04,Palatin Technologies To Present At The 12th Annual BIO Investor Forum
2013-05-24,Biotech Stock Mailbag: Amarin, MannKind, Palatin
2013-05-02,Palatin Technologies Announces Notification Of Patent Allowance On Melanocortin Receptor-Specific Peptides For Sexual Dysfunction
2013-03-19,Palatin Technologies Announces Notification Of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
2013-03-15,Palatin Technologies To Present At The 25th Annual ROTH Conference
2013-03-04,Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference
2013-02-07,Palatin Technologies, Inc. To Present At 15th Annual BIO CEO & Investor Conference
2013-01-03,Palatin Technologies Receives $1.75 Million From Sale Of New Jersey State Tax Credits
2012-11-20,Palatin Technologies, Inc. To Present At The 24th Annual Piper Jaffray Healthcare Conference
2012-11-12,Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
2012-11-08,Palatin Technologies Reports Positive Results For Phase 2B Bremelanotide Female Sexual Dysfunction Trial
2012-10-26,5 Stocks Poised for Breakouts
2012-09-11,Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript
2012-09-10,Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
2012-09-07,Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration With AstraZeneca
2012-07-02,Palatin Technologies, Inc. Announces Pricing Of $35 Million Private Placement Of Common Stock And Warrants
2012-06-19,Palatin Technologies Announces Halting Of Phase I Clinical Trial Of Obesity Compound In AstraZeneca Research Collaboration
2012-05-14,Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript
2012-03-08,Palatin Technologies Completes Enrollment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
2012-03-07,Palatin Technologies, Inc. To Present At The 24th Annual ROTH OC Growth Stock Conference
2012-02-15,Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript
2012-02-09,Palatin Technologies To Present At 14th Annual BIO CEO & Investor Conference
2012-01-17,Palatin Technologies Receives $1.1 Million From Sale Of New Jersey State Tax Credits
2012-01-16,Palatin Technologies To Present At BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
2011-11-30,Palatin Technologies To Present At Windhover's Therapeutic Area Partnerships Conference
2011-11-15,Palatin Technologies CEO Discusses F1Q12 Results - Earnings Call Transcript
2011-10-21,Palatin Technologies To Present At 10th Annual BIO Investor Forum
2011-09-22,Palatin Technologies CEO Discusses F4Q2011 Results - Earnings Call Transcript
2011-09-09,Palatin Technologies, Inc. To Present At The Rodman & Renshaw Annual Global Investment Conference
2011-08-04,Palatin Announces Commencement Of A Phase 1 Trial For Obesity Compound In Collaboration With AstraZeneca
2011-06-28,Palatin Technologies, Inc. Initiates Enrollment In Phase 2b Trial With Bremelanotide In Women With Female Sexual Dysfunction
2011-06-23,Alan Dunton, M.D., Joins Board Of Directors Of Palatin Technologies, Inc.
2011-06-21,Palatin Technologies, Inc. Issued U.S. Patent For Key Component In PL-3994 Drug Candidate
2011-06-15,Palatin Technologies, Inc. Announces Presentation And Publication On Validation Of Scale For Subjective Male Sexual Arousal
2011-05-16,Palatin Technologies CEO Discusses F3Q2011 Results - Earnings Call Transcript
2011-05-11,Palatin Technologies, Inc. Announces Results Of Annual Stockholders' Meeting
2011-03-09,Palatin Technologies, Inc. To Present At The ROTH 23rd Annual OC Growth Stock Conference
2011-03-03,FDA Clears Palatin Technologies' IND Filing To Commence Clinical Studies For Asthma
2011-03-01,Palatin Technologies, Inc. Closes $23 Million Public Offering
2011-02-24,Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript
2011-02-24,Palatin Technologies, Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants
2011-02-23,Palatin Technologies, Inc. Announces Proposed Public Offering Of Common Stock And Warrants
2011-02-04,Palatin Technologies Listing Compliance Plan Accepted By NYSE Amex
2010-12-02,Palatin Technologies Receives Non-Compliance Letter From NYSE Amex
2010-11-16,Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript
2010-11-16,Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
2010-11-02,Palatin Technologies, Inc. Receives $978,000 In Grants Under The Patient Protection And Affordable Care Program
2010-10-01,Palatin Technologies To Present At 9th Annual BIO Investor Forum
2010-09-30,Globecomm Systems - Upgrades & Downgrades
2010-09-27,Palatin CEO Discusses F4Q2010 Results - Earnings Call Transcript
2010-09-24,Palatin Announces Strategic Realignment Of Operations
2010-09-10,Palatin Technologies To Present At Rodman & Renshaw Annual Global Investment Conference
2010-08-17,Palatin Technologies, Inc. Announces Positive Safety Results In Subcutaneous Bremelanotide Trial In Men
2010-06-25,Palatin Technologies, Inc. To Raise $2.0 Million Dollars In Registered Direct Offering
2010-06-24,Palatin Technologies, Inc. Announces Last Patient Dosed And Database Lock In Subcutaneous Bremelanotide Trial In Men
2010-05-24,Bill Gross Buys Into Pimco Funds
2010-05-13,Palatin Technologies, Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript
2010-05-04,Palatin Technologies, Inc. Issued U.S. Patent And Receives Patent Allowance On Seven Additional Patents
2010-03-23,Palatin Technologies, Inc. Receives $2.5 Million From AstraZeneca
2010-02-25,Palatin Technologies, Inc. To Raise $2.6 Million Dollars In Registered Direct Offering
2010-02-16,Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2010 Results; Teleconference And Webcast To Be Held On February 16, 2010
2010-02-09,Palatin Technologies, Inc. Announces Dosing Of Subcutaneous Bremelanotide Trial In Men
2009-12-01,Palatin Technologies, Inc. Issued U.S. Patent For Heart Failure Drug Candidate
2007-11-09,Friday's Health Winners & Losers
2007-09-14,Friday's Small-Cap Winners & Losers
2007-08-30,Thursday's Small-Cap Winners & Losers
2007-08-30,Thursday's Health Winners & Losers
2007-01-31,Wednesday's Small-Cap Winners & Losers
2006-01-13,Four Stocks Ready to Get Off the Canvas
2005-04-12,King Pharmaceuticals' Sales Guidance Is Light
2004-04-13,Time Remains to Right the Boat
,
